Abstract Introduction and Objective: When feasible, the treatment for all-invasive bladder
cancer is radical cystectomy. The aim of the present study was to analyze the prognostic …

Purpose: The effect of bladder cancer histological subtypes other than transitional cell
carcinoma (nonTCC) on clinical outcomes remains uncertain. We conducted a multi …

Purpose: We present the characteristics and outcomes of a large, contemporary,
consecutive series of patients treated with radical cystectomy and pelvic lymphadenectomy …

The intent of nonmuscle invasive bladder cancer management is to control recurrence and
progression and to identify invasive tumours at the earliest possible stage. To obtain exact …

Purpose: While radical cystectomy remains the treatment of choice for invasive transitional
cell carcinoma, the importance of its timing has been increasingly scrutinized. We …

Objective: To investigate the oncological outcome of radical cystectomy for muscle invasive
bladder (MIBC) on cancerspecific survival. Material and Method: A consecutive series of …

Objective To examine whether the outcome of cystectomy for invasive transitional cell
carcinoma (TCC) of the bladder was influenced by the type of disease at initial presentation …

The management of transitional cell carcinoma of the bladder (TCCB) presents a challenge
to urological surgeons due to the diversity of patient factors, stage at presentation and …

Purpose: Upper tract transitional cell carcinoma (UTTCC) is a relatively rare tumor. Overall 5-
year disease specific survival is in the range of 16.5% to 95% depending on stage. In this …

The goal of this study is exploring the disparity of incidence, mortality and survival outcome
among transitional cell carcinomas (TCCs) in the 4 parts of urinary system. This study …